Skip to content

Study of practice pharmacist-led management of long-term pain

A pilot randomised controlled trial of general practice-based, pharmacist-led, management of chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN06131530
Enrollment
216
Registered
2010-01-29
Start date
2010-01-04
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain Signs and Symptoms Pain

Interventions

There are three arms in this study: 1. Pharmacist review: pharmacist medication review with recommendations for changes in pain medication made to GPs for indirect implementation 2. Pharmacist prescri

Sponsors

University of Aberdeen (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. GP practices: any general practice with an existing practice pharmacist service 2. Pharmacists: a registered prescriber with evidence of appropriate professional indemnity cover 3. Patients: 3.1. Male and female patients 3.2. Aged over 18 years old 3.3. Chronic pain (defined as pain lasting more than 13 weeks) 3.4. Receiving regular prescribed medication for pain

Exclusion criteria

Exclusion criteria: 1. GP practices: no existing practice pharmacists 2. Pharmacists: not a registered prescriber or does not have evidence of appropriate professional indemnity cover 3. Patients: 3.1. Under 18 years old 3.2. Not experiencing chronic pain 3.3. Concomitant severe mental health problems 3.4. Terminal illness 3.5. Recent bereavement 3.6. Known alcohol or drug addiction 3.7. Unable to give informed consent 3.8. Malignant pain 3.9. Recent participation in research 3.10. Any other reason at the discretion of the GP for whom the intervention is considered inappropriate

Design outcomes

Primary

MeasureTime frame
Information from this pilot RCT will be used to inform final selection of a single primary outcome measure from the following: 1. 12-item short form health survey (SF-12) 2. Health Utilities Index mark 2 and mark 3 (HUI 2/3) Administered for self-report, postal questionnaire at baseline, three and six month follow-up.

Secondary

MeasureTime frame
1. The Chronic Pain Grade (assessing severity of pain) 2. The Hospital Anxiety and Depression Scale (assessing level of anxiety and depression) Questionnaires are administered as self-report, postal questionnaire at baseline, three and six month follow-up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026